Abstract:Background Primary Sjögren’s syndrome (pSS) is a commono systemic autoimmune disease, characterised by lymphocytic infiltration of the secretory glands and different extraglandular manifestations. Besides haematological disorders are prevalent but not well recognised in patients with pSS. Objectives Our aim is to determine the existence of cytopenia at diagnosis or during follow-up of our pSS patients as well as the associated factors. Methods A cohort of pSS patients that had been followed-up in the Department of Rheumatology, Tongji hospital of Tongji University, from 2011 to 2017 was retrospectively assessed. Clinical and laboratory findings about the patients were recorded. Results Out of 232 pSS patients composing the cohort, cytopenia was already present in 55.60% (n=129) at the time of diagnosis. Anaemia was detected in 30.17% (n=70), leukopenia in 37.5% (n=87), neutropenia in 22.41% (n=52), and thrombocytopenia in 26.72% (n=62) of patients. The proportion of patients with cumulative cytopenia was 6.47% (n=15). Cumulative cytopenia was disease-related in 5.60% (n=13) and medication-related in 0.86% (n=2) of the patients. In patients with cytopenia at the time of diagnosis, erythrocyte sedimentation rates (ESR) were higher (p<0.001), C3 and C4 hypocomplementemia was more prevalent (p<0.001, p=0.060), and they were positive for anti-SSB at a greater proportionand (p=0.058). Hyperglobulinemia, C3 hypocomplementemia, positive anti-SSA and anti-SSB might increase the incidence of anaemia in pSS, with OR of 2.700, 2.042, 1.537 and 1.901, respectively. In addition, logistic regression analysis suggest C3 hypocomplementemia might be associated with different types Leukopenia(p<0.01), while abnormal Transaminase and C4 hypocomplementemia are independent risk factors for thrombocytopenia with a OR of 4.171 (1.516–11.480) and 5.697 (1.662–19.523). Cytopenia in pSS patients not either at diagnosis or during follow-up, was always easy to be ameliorated, but several cases leaded to unfavourable outcome. Conclusions The most common haematological disorders in pSS patients are leukopenia, and cytopenia in pSS patients might be related to disease activity. References [1] Tim Both, et al. Reviewing primary Sjögren’s syndrome: beyond thedryness – From pathophysiology to diagnosis and treatment. Int. J. Med. Sci. 2017, 14(3): 191–200. [2] García-Carrasco M, et al. Serologic features of primary Sjögren’s syndrome: Clinical and prognostic correlation. Int J Clin Rheumtol2012;7(6):651–659. Acknowledgements We would like to thank all of the participants who took part in the studies featured in this research. The present work was sponsored by the National Natural Science Foundation of China (No. 81273295, 81302562, 81671598), China International Medical Exchange Foundation (Z-2014–06–2–1620), and Shanghai Sailing Program (No.17YF1417200). Disclosure of Interest None declared

Sjogren'S Syndrome In China

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Focus on Effects of Chinese Medicine on Improving Anxiety-Depression and Quality of Life of Patients with Primary Sjögren's Syndrome.

Effect of Chinese Herbal Medicine for Nourishing Yin, Supplementing Qi, and Activating Blood on the Th1/Th2 Immune Balance in Peripheral Blood in Patients with Primary Sjogren's Syndrome.

Pathogenesis and diagnostic and therapeutic characteristics of Sjogren's syndrome based on TCM theory of five zang-organs

Prevalence of primary Sjögren's syndrome in China

Primary Sjögren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients.

Effect of Chinese Herbal Medicines for Nourishing Yin, Supplementing Qi, and Activating Blood on Reproductive Endocrine Activity and Immune Functions in Patients with Primary Sjogren's Syndrome.

[Recommendations of Diagnosis and Treatment of Primary Sjögren's Syndrome in China].

Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjogren's syndrome

Characteristics of Chinese patients with primary Sjögren's syndrome: preliminary report of a multi-centre registration study.

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Challenges in Treatment of Primary Sjögren’s Syndrome and Opportunities for Chinese Medicine

The clinical characteristics of 573 cases of primary Sj(o)gren's syndrome

AB0637 Haematological Involvement of Primary Sjogren’s Syndrome Patients in a Single Centre Study of 232 Chinese Cases

From Molecular Mechanism to the Etiology of Sjogren Syndrome

Seronegative primary Sjögren's syndrome, a distinct subtype of primary Sjögren's syndrome in Chinese patients

Traditional Chinese Medicine for Sjögren’s Syndrome: a National Survey of Attitudes and Perceptions among Chinese Patients and Rheumatologists

Traditional Chinese medicine for sjögren's syndrome: a national survey of attitudes and perceptions among Chinese patients and rheumatologists

Syndromes Clinical Literature Study of the Traditional Chinese Medicine to Sjogren's Syndrome

Advances in Pathogenesis of Sjögren’s Syndrome